Clinical Trial Update: A Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of Itacitinib [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 rollover study of Itacitinib to provide continued treatment for participants previously enrolled in Itacitinib st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis Obliterans Syndrome
• Graft-versus-host Disease
• Myelofibrosis

Drugs mentioned

• Itacitinib (itacitinib)

Snippet

Sponsor: Incyte Corporation | Conditions: Myelofibrosis, Postlung Transplant (Bronchiolitis Obliterans) | Phase 2 | Status: ACTIVE_NOT_RECRUITING